Company intelligence / Profile preview

Tissuemed

Leeds, West Yorkshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

Tissuepatch is a commercially available, advanced self-adhesive surgical sealant film for internal tissue sealing, designed for broad use across surgery specialties, showing minimal swelling and strong adhesion, acquired and now incorporated into BD’s biosurgery portfolio; no conventional clinical trial results as it is categorized as a device

Therapeutic areas: Other
Modalities: DeviceHydrogel-based drug delivery therapy (applied as thin, self-adhesive surgical sealant films)
Industry: Surgical Medical Devices

Partnerships

Integration into BD's biosurgery portfolio (key commercial partnership with BD)

Beyond the preview

Go deeper on Tissuemed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissuemed.

Explore the full profile